Drug companies' evidence to justify advertising
Date
1989
Authors
Wade, V.A.
Mansfield, P.R.
McDonald, P.J.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
The Lancet, 1989; 334(8674):1261-1264
Statement of Responsibility
V.A. Wade, P.R. Mansfield, P.J. Mcdonald
Conference Name
Abstract
Ten international pharmaceutical companies were asked by letter to supply their best evidence in support of marketing claims for seventeen products. Fifteen replies were received. Seven replies cited a total of 67 references: 31 contained relevant original data and only 13 were controlled trials, all of which had serious methodological flaws. There were four reports of changes in advertising claims and one company ceased marketing nikethamide in the third world. Standards of evidence used to justify advertising claims are inadequate.
School/Discipline
Dissertation Note
Provenance
Description
Originally published as Volume 2, Issue 8674
Access Status
Rights
© 1989 Published by Elsevier Ltd.